Comprehensive Brain Imaging Review: How Cannabis Changes Brain Structure and Function

A review of 103 brain imaging studies found regular cannabis use causes structural changes (especially in hippocampus and amygdala), alters cognitive processing, reduces dopamine function, and downregulates CB1 receptors.

Weinstein, Aviv et al.·Current pharmaceutical design·2016·Strong EvidenceReview
RTHC-01300ReviewStrong Evidence2016RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

This comprehensive review synthesized 103 structural and functional brain imaging studies of cannabis users published between 2000 and 2016, providing the most complete picture to date of how cannabis affects the human brain.

Structural findings: Regular cannabis use was associated with volumetric and tissue changes, particularly in the hippocampus (memory) and amygdala (emotion). Both gray matter and white matter alterations were documented.

Functional findings: Cannabis affected attention, memory, decision-making, emotional processing, and social cognition. Brain imaging showed that regular users recruited additional brain regions to compensate for impaired function, achieving similar performance through greater neural effort.

Dopamine findings: Pharmacological studies showed a modest increase in striatal dopamine after acute THC. However, chronic users showed reduced dopamine transporter occupancy and reduced dopamine synthesis, but not reduced dopamine receptor density. This pattern differs from other drugs of abuse.

CBD vs THC: Studies confirmed that THC and CBD have opposing effects on emotion, cognition, and brain activation, with CBD protecting against THC's psychoactive effects.

CB1 receptor imaging: PET studies showed downregulation of CB1 receptors in regular cannabis users.

Key Numbers

103 studies reviewed (structural and functional). Hippocampus and amygdala most consistently affected structurally. Chronic use: reduced dopamine transporter occupancy and synthesis. CB1 receptor downregulation confirmed by PET. CBD showed protective effects against THC.

How They Did This

Systematic literature review of 103 eligible structural and functional brain imaging studies of recreational and regular cannabis users published January 2000 to January 2016. Studies included MRI, fMRI, PET, and pharmacological challenge studies.

Why This Research Matters

This is one of the most comprehensive summaries of cannabis neuroimaging research. By integrating structural, functional, dopaminergic, and receptor imaging data, it provides a unified picture of how cannabis reshapes the brain. The compensatory recruitment finding is particularly important: normal task performance can mask underlying neural changes.

The Bigger Picture

This review establishes that regular cannabis use produces measurable, consistent changes across multiple levels of brain organization: structure, function, neurochemistry, and receptor availability. The fact that some changes may be compensated for behaviorally while still being detectable neurally raises important questions about long-term brain health and cognitive reserve.

What This Study Doesn't Tell Us

Most studies were cross-sectional, limiting causal conclusions. Study populations, methods, and definitions of "regular use" varied widely. Publication bias may favor studies finding differences. The review period ends in early 2016 and does not capture more recent neuroimaging advances.

Questions This Raises

  • ?Are the structural and receptor changes reversible with sustained abstinence?
  • ?Does the age of cannabis initiation affect the magnitude of brain changes?
  • ?How do the brain effects of high-potency cannabis products compare to the products studied?
  • ?Do the compensatory neural mechanisms eventually fail with prolonged heavy use?

Trust & Context

Key Stat:
103 imaging studies show structural, functional, dopaminergic, and receptor changes from regular cannabis use.
Evidence Grade:
Strong evidence from a comprehensive review of 103 imaging studies, providing convergent evidence across multiple brain imaging modalities.
Study Age:
Published in 2016. Neuroimaging of cannabis effects continues to advance with larger sample sizes and more sophisticated methods.
Original Title:
Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Published In:
Current pharmaceutical design, 22(42), 6366-6379 (2016)
Database ID:
RTHC-01300

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Does cannabis change the brain?

Yes. This review of 103 imaging studies found consistent structural changes (especially in the hippocampus and amygdala), altered brain function during cognitive tasks, reduced dopamine synthesis, and downregulated cannabinoid receptors in regular cannabis users.

Can the brain compensate for cannabis effects?

Partially. Brain imaging studies show regular cannabis users often recruit additional brain regions to achieve normal task performance. This compensatory recruitment may mask underlying neural changes, though whether this compensation is sustainable long-term is unknown.

Read More on RethinkTHC

Cite This Study

RTHC-01300·https://rethinkthc.com/research/RTHC-01300

APA

Weinstein, Aviv; Livny, Abigail; Weizman, Abraham. (2016). Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.. Current pharmaceutical design, 22(42), 6366-6379. https://doi.org/10.2174/1381612822666160822151323

MLA

Weinstein, Aviv, et al. "Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.." Current pharmaceutical design, 2016. https://doi.org/10.2174/1381612822666160822151323

RethinkTHC

RethinkTHC Research Database. "Brain Imaging Studies on the Cognitive, Pharmacological and ..." RTHC-01300. Retrieved from https://rethinkthc.com/research/weinstein-2016-brain-imaging-studies-on

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.